Last approved inhibitor(s)
Pexidartinib, Entrectinib, Fedratinib, Upadacitinib, Alpelisib
New inhibitor(s) this month
Ceralasertib, Derazantinib, Lazertinib, Pralsetinib, Ripretinib, Rivoceranib, Samotolisib
SourcesStructures and data are compiled by SB&C Team from the Chembl Drugstore and clinicaltrials.gov.
Please note that we provide information about inhibitors having known International Nonproprietary Names (INN). For more information see the USAN nomenclature.